Table 1.
Number | Sexual | Age | Site | Subtype | Maximum cross-section(cm) | Neoplastic nature | Follow up (months) |
Prognosis |
---|---|---|---|---|---|---|---|---|
1 | F | 43 | The right broad ligament | AML | 18.9 | Low malignant | 38.1 | Nonrelapse |
2 | F | 66 | The upper portion of the left kidney | AML | 3.1 | Benign | 91.8 | Nonrelapse |
3 | F | 41 | The lower pole of the left kidney | AML | 1 | Benign | 32.3 | Nonrelapse |
4 | F | 44 | The middle of the right kidney | AML | 2.8 | Benign | 31.0 | Nonrelapse |
5 | M | 65 | Hepatic segments V, VI and VIII | AML | 6.7 | Benign | 3.1 | Nonrelapse |
6 | F | 36 | Hepatic segments VI | AML | 3.3 | Benign | 41.6 | Nonrelapse |
7 | F | 36 | Hepatic segments VI, VII and VIII | AML | 4.8 | Benign | 8.4 | Nonrelapse |
8 | F | 34 | Left lateral liver | AML | 3.1 | Benign | 4.9 | Nonrelapse |
9 | M | 62 | Lower lobe of the right lung |
pulmonary clear cell “sugar” tumor |
2.5 | Benign | 3.2 | Nonrelapse |
10 | M | 30 |
Retroperitoneal (RP) |
AML | 16 | Malignant | 69.8 | Nonrelapse |
11 | M | 17 | RP | AML | 19.5 | Moderate malignant | 4.6 | Nonrelapse |
F: female M: male